Molecular characterization and clinical impact of TMPRSS2-ERG rearrangement on prostate cancer: comparison between FISH and RT-PCR..     ///    The presence of TMPRSS2-ERG rearrangement was observed in 56.6% of cases.     ///    No association between TMPRSS2-ERG status and clinicopathological parameters nor biochemical progression and clinical progression free survival was found. 